Canada Pension Plan Investment Board
DSGN icon

Canada Pension Plan Investment Board’s Design Therapeutics DSGN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472K Sell
32,600
-27,800
-46% -$347K ﹤0.01% 1282
2026
Q1 		$643K Buy
60,400
+5,800
+11% +$58.7K ﹤0.01% 1144
2025
Q4 		$512K Buy
+54,600
New +$428K ﹤0.01% 1297

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Canada Pension Plan Investment Board's DSGN Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Design Therapeutics (DSGN) stake by 46% in Q2 2026, selling an estimated $347K and leaving 32,600 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

Canada Pension Plan Investment Board first reported a position in DSGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $643K in Q1 2026. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Canada Pension Plan Investment Board held 32,600 shares of Design Therapeutics worth $472K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 27,800 Design Therapeutics shares in Q2 2026, an estimated $347K.
  • Design Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1282 holding.
  • Canada Pension Plan Investment Board first reported a position in Design Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's Design Therapeutics position peaked at $643K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.